Kemps Medical Transcription Se Los Angeles, CA - 90062

Kemps Medical Transcription Se is categorized under Formal Writing Services in Los Angeles, CA and active since 2002.

Kemps Medical Transcription Se was established in 2002, and today employs 1 to 4, earning $0 to $49.999 per year. This is a Formal Writing Services business, which does work in the B2B market, and is classified as a Formal Writing Services, under code number 561410 by the NAICS.

If you are seeking more information, feel free to contact Mertha Kemp at the company’s single location by writing to 4713 South Van Ness Avenue, Los Angeles, California CA 90062 or by phoning (323) 292-3725. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Kemps Medical Transcription Se
Contact Person: Mertha Kemp
Address: 4713 South Van Ness Avenue, Los Angeles, California 90062
Phone Number: (323) 292-3725
Annual Revenue (USD): $0 to $49.999
Founded: 2002
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Formal Writing Services
SIC Code: 7338
NAICS Code: 561410
Share This Business:

Kemps Medical Transcription Se was started in 2002 to provide professional Formal Writing Services under the SIC code 7338 and NAICS code 561410. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $0 to $49.999 per annum.

Feel free to contact Mertha Kemp for inquiries that concern Kemps Medical Transcription Se by calling the company number (323) 292-3725, as your correspondence is most welcome. Additionally, the physical location of the single location of Kemps Medical Transcription Se can be found at the coordinates 34.000305,-118.317295 as well as the street address 4713 South Van Ness Avenue in Los Angeles, California 90062.

For its online presence, you may visit Kemps Medical Transcription Se’s website at and engage with its social media outlets through on Twitter and on Facebook.